Malinis, Jaylord Lee A.

HRN: 21-26-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/16/2022
06/23/2022
IV
115 Mg
Q6H
PCAP-C
Waiting Final Action 
06/20/2022
CEFTRIAXONE 1G (VIAL)
06/20/2022
06/25/2022
IV
240 Mg
Q12Hrs
PCAP C
Waiting Final Action 
06/24/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
06/24/2022
06/30/2022
ORAL
2ml
Q12Hrs
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: